7.200
−1,37%
2026-10-12
Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +6628.9% | +2284.5% | 3 / 3 | +35.5% | +8.44 pp | +3.30 pp | +8.0% | 0.00 | 5.13 | 63,3 | +35,5% | 2,0 | +6.628,9% | 5.13 | 9.45 | −45,7% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 7.200 (close price on 2026-10-12)EPS (TTM): 1.404
Financial charts
1.Revenue & growth
VND bn63,3Q2/26
1.Revenue & growth
VND bn63,3Q2/26
2.Profit & growth
VND bn-0,65Q2/26
3.Profit mix (Penman)
VND bn10,7Q2/26
4.Margins & cost structure
%17.3%Q2/26
5.Returns & cash cycle
% · days7.0%Q2/26
6.Earnings quality & cash
VND bn31,5Q2/26
7.Asset structure
VND bn163Q2/26
8.Funding & debt health
VND bn · times163Q2/26
9.Revenue backlog
VND bn3,02Q2/26
10.Valuation
times · %6,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-81Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
112%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26